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Background: Diabetes predicts worse outcomes after coronary artery bypass grafting (CABG) We hypothesized that
a strategy using radial artery (RA) conduit(s) would improve outcomes and long term survival for diabetic patients
undergoing CABG with Left Internal Thoracic Artery (LITA) and RA grafts, with or without additional saphenous vein
(SV) when compared with outcomes for patients bypassed with LITA and SV but no RA.
Methods: A propensity matched study of long term survival in diabetic patients who had isolated first time CABG
from January 1995 to June 2010 at an urban academic medical center in New York City. Our primary endpoint was
all cause mortality determined from the Social Security Death Index in December 2010.
Results: We compared our 15 year outcomes in diabetic patients after isolated, primary CABG: 642 patients
received LITA + RA +/− SV (RA group) vs. 1201 patients who had LITA + SV only (SV group). Propensity scoring for
multiple preoperative and operative variables matched 409 patients from each group: 68% were male with an
average age of 61 years and ejection fraction averaged 47%. Average grafts per patient was 3.7 for both groups
with 2.3 arterial grafts per patient for the RA group. Operative (30 day) mortality was 0.1% RA vs. 1.9% SV,
(p<0.0001) For propensity matched patients, mortality was 0.25 RA vs 0.5% SV. (p<0.001) The incidence of major
complications was similar in both groups. Kaplan Meier actuarial survival at 1, 5, 10 and 12 years was 98%, 89%, 77
and 70% for RA vs. 96%, 87%, 64% and 59% for SV (p<0.006.) By Cox multivariate analysis significant predictors of
mortality were: age, stroke, peripheral vascular disease, COPD, creatinine > 2.5mg/dl and low ejection fraction but
only RA use predicted better survival [HR 0.683, CI 0.507- 0.920, p=0.0122].
Conclusion: For diabetic patients having CABG with LITA, use of radial artery conduit adds a substantial and
sustained survival advantage compared to LITA and vein. Optimal revascularization for diabetics with multi vessel
disease is redefined.
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Surgical revascularization (CABG) remains the best evi-
dence based treatment for atherosclerotic multivessel
coronary artery disease in patients with diabetes, despite
improvements in percutaneous interventional techniques
(PCI) and medical therapy. The Achilles heel of PCI,
especially in diabetics, is still the more frequent need
for reintervention in the first years after the procedure
[1]. In the long term, CABG too is vulnerable, because,
while excellent and sustained long term patency of
LITA grafts have been reported beyond 20 years, vein
graft failure rates approach 30% at 10 years and 68% at
15 years [2,3].
Our group shares the usual concerns in diabetic patients
about using both internal thoracic arteries which can com-
promise blood supply of the sternum and interfere with
wound healing. In diabetic patients, all outcomes after
CABG are known to be worse [4]. Failure of saphenous
vein grafts is known to occur more often in diabetics [5],
and we postulated that such vein graft failure might
reduce long term survival in these patients. In our ob-
servational series [6], of over 1,500 consecutive isolated
CABG patients, those receiving a radial artery (RA)
graft, whether diabetic or not, experienced the same
excellent and sustained medium to long-term survival.
We aim in this present study to examine this import-
ant observation in detail and test the hypothesis that
use of the RA as a second arterial conduit improves
long term survival after CABG for diabetic patients.
Methods
The Division of Cardiac Surgery at the Beth Israel Med-
ical Center maintains a prospectively collected database
on all patients undergoing cardiac surgery as required
for the mandatory and audited New York State Depart-
ment of Health Cardiac Surgery Reporting System. All
data are reported to the State and also are maintained in
a parallel, separate database. This study was approved by
the Institutional Review Board, which waived written
informed consent. Analysis of these data was retrospective
Our study population was drawn from the 4,500 patients
who underwent first-time isolated CABG at our center
from January 1995 to June 2010. From this cohort, the
1843 consecutive diabetic patients were selected to form
the study group for this current analysis. Throughout
the study period the New York State Cardiac Surgery
Reporting defined diabetes as any patient on either oral
hypoglycemic drugs or insulin prior to hospital admis-
sion for CABG.
In all these patients the LITA was grafted to the LAD,
and additional grafts were constructed with SV or RA as
necessary. Throughout the study, all SV harvest was
endoscopic; RA harvest before 2000 was open and exclu-
sively endoscopic since mid 2000. Our indications forusing a RA graft were: age less than 60 years in the early
years and then more liberally; unavailable or unsuitable
SV accounted for our RA use in older patients. RA were
used to bypass target arteries affected by stenosis of at
least 70% usually in the left sided circulation. Patients on
or likely to need hemodialysis were excluded to preserve
potential dialysis access.
Throughout the period covered by this study, strict
control of blood glucose level post CABG (target level
80–120 mg/dl) was protocol driven and supervised by
active oversight from the Diabetes team comprising
Endocrinologists in training and Faculty from the Friedman
Division of Endocrinology. The same team transitioned
patients from continuous infusion insulin to a personalized
regimen for glycemic control.
Surgical and radial artery harvesting technique
Details of RA harvest and surgical technique have been
published elsewhere. (5) Over the study period RA use
increased from ½ to 2/3 of all our CABG patients. In
brief, operations were conducted under general anesthesia,
on pump using cold blood cardioplegic arrest and a single
cross clamp technique. RA grafts were generally used as
aortocoronary bypasses; proximal anastomosis to another
RA, SV or very rarely, LITA was made only when lack of
RA length or aortic disease precluded direct aortic
anastomosis. Off pump procedures (usually for exten-
sive aortic disease) were performed in 48 (2.6%) of all
patients (3.3% of the SV patients and 1.2% of the RA
patients) but none of the propensity-matched patients
had off pump surgery.
Harvest of RA was undertaken by our Physician As-
sistant or RNFA after Allen‘s test and pulse oximetry
confirmed adequate collateral circulation. Less than 2%
of evaluated RA were not harvested. No patient suffered
postoperative hand ischemia. An open no-touch tech-
nique was used for harvest until 1999; thereafter, and
building on extensive experience with endoscopic vein
harvest, endoscopic RA harvest was performed with a
Harmonic scalpel. After 2000, harvest was exclusively
endoscopic and there has not been a single conversion
to open technique. We administer intravenous Diltiazem
after induction of anesthesia and postoperatively switch
to oral nitrates or Diltiazem (ideally maintained for at
least 6 months). All patients received aspirin, statins,
beta-blockers and ACE inhibitors postoperatively (unless
contraindicated).
The harvested RA was stored until use in a solution of
the patient’s heparinized venous blood (containing circu-
lating Diltiazem) mixed with 1% Papaverine. While RA
from diabetic patients for the most part are excellent
conduits, we have found occasional areas of minor calcifi-
cation and thickening [7]. A rare harvested RA had to be
discarded because of unsuspected intraluminal disease.
Table 1 Diabetic patients before propensity matching
Radial n=642 Vein n=1201 P value
All-cause mortality 15.42% 38.13% <0.0001
Mean age, years 58.6 (±8.1) 67.3 (±8.8) <0.0001
Males 72.59% 59.03% <0.0001
Hispanic 29.75% 28.06% 0.4443
Race
White 62.15% 60.28% 0.517
AA 11.99% 16.65% 0.003
Other 25.86% 23.06% 0.201
Mean EF 48.3% (± 11.8) 45.9% (±13.5) <0.0001
Years since surgery 6.7 (±3.9) 6.9 (±4.5) 0.257
BMI 29.8 (±5.5) 28.8 (±5.4) <0.0001
Transmural MI 31.62% 36.97% 0.0219
Stroke 8.10% 9.91% 0.2023
Carotid disease 7.31% 17.24% <0.0001
Aortoilac disease 2.02% 4.16% 0.0161
Femoral PVD 8.72% 12.99% 0.0062
Hemodynamics unstable 0.93% 1.67% 0.2051
Hypertension 71.18% 79.60% <0.0001
Current CHF 6.39% 12.16% <0.0001
COPD 20.72% 32.47% <0.0001
Ascending aortic disease 3.12% 8.99% <0.0001
Creatinine > 2.5 mg/dL 1.87% 7.16% <0.0001
Coronary vessel disease
Triple 86.2% 81.5% 0.0001
Double 11.25% 13.47% 0.0409
Single 2.05% 3.74% 0.0002
Left main 27.03% 31.4% 0.0017
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Statistical analysis was performed with the SAS system
v9.2 (SAS Institute, Cary NC). Continuous variables are
expressed as mean and standard deviation, and were
analyzed using the t test. Categorical variables are
expressed as percentages and were analyzed using the Chi
Square and Fisher’s exact tests. The primary endpoint in
this study was all cause mortality obtained from the Social
Security Death Index (searched in December 2010).
Patient survival was estimated by the Kaplan Meier
method, and the log-rank test was used to assess sur-
vival differences between groups. Hazard ratios and
95% confidence intervals are presented. Cox regression
was used to assess independent predictors of survival.
Propensity matching
After excluding 47 patients on hemodialysis (1 RA and
46 SV) and 29 patients who died within 30 days after
CABG, 1767 patients were subjected to propensity matching
using the sequential nearest neighbor selection [7]. Pro-
pensity matching employed the following variables: age,
gender, year of surgery, surgeon, ejection fraction, hyper-
tension, transmural myocardial infarction, stroke, carotid
disease, peripheral vascular disease, hemodynamic in-
stability at time of procedure, current CHF, COPD, exten-
sive ascending aortic atherosclerosis, extent of coronary
artery disease, number of grafts per patient, and serum
creatinine level > 2.5 mg/dl.
We used these variables as predictors in a logistic re-
gression model – with radial artery use as the dependant
variable. The output of this logistic regression model
generated propensity scores for each patient that were
then used to select pairs from among RA and SV
patients, where each pair had probability scores differing
by no more than 1%. 818 patients were included as
we matched 409 patients from each of the two groups
(RA and SV).
Results
We studied in retrospect the 1843 consecutive diabetic
patients, who underwent isolated, primary CABG in our
institution January 1995 - June 2010. Of these, 1201
patients were bypassed with a LITA graft and SV, as
needed, (GROUP SV) while 642 patients were grafted
with LITA and RA with additional SV as needed
(GROUP RA).
Table 1 summarizes the preoperative risk factors, and
Table 2 the operative and postoperative data for all 1843
patients. Briefly, the patients grafted with RA were younger
(mean age 58.6years ±8.1 vs 67.3 ±8 years), mostly male
(72.6 vs 67.3%) and had fewer comorbidities. Preoperative
vascular disease, especially carotid disease was substantially
more prevalent before matching in the SV group, but
interestingly not previous stroke. Single-vessel diseasewas uncommon, and left main stenosis was present in
30%. Reflecting our hospitals location and the commu-
nities it serves, surgical priority was strongly tilted to
urgent surgery, (i.e. within the same hospital admission).
Less than 25% of our patients had elective surgery; fewer
than 5% had emergency surgery. Almost no patients in
the RA group were hemodynamically unstable: despite
the dexterity of our harvester, RA harvest adds 20–30
minutes to the procedure prior to sternotomy.
The distribution of coronary artery disease was quite
similar but there was a slight but significantly greater
incidence of triple vessel disease (86.2% vs 81.5%) in the
RA group. None of the patients in the cohort had
bilateral ITA grafts. We very rarely use the LITA as a
sequential graft and in diabetic patients avoid bilateral
ITA harvest. In keeping with our intent to achieve
complete arterial revascularization of the left coronary
artery system, 35% of RA patients received more than 2
arterial grafts, mostly by using the RA as a “manufactured”
Y graft. Bilateral RA grafts were harvested from 58
Table 2 Diabetic patients before propensity matching
Radial n=642 Vein n=1201 P value
Mean cross-clamp 71.8 (±20) 61.6 (±21) <0.0001
Mean perfusion 94.8 (±25) 85.4 (±29) <0.0001
Grafts/patient 3.84 (±0.9) 3.56 (±0.8) <0.0001
Priority
Elective 22.8% 19.12% 0.0100
Urgent 72.97% 75.15% 0.2370
Emergent 4.2% 5.74% 0.4400
Operative mortality 0.2% 1.9% <0.0001
Permanent stroke 0.93% 1.25% 0.0059
Perioperative MI 0.67% 0.78% 0.6548
Sternal infection 1.4% 2.75% 0.2506
Septicemia 1.71% 3.66% <0.001
Reop. for bleeding 1.71% 2.16% 0.1694
Respiratory failure 2.665% 5.25% <0.0001
Renal failure 0.93% 2.91% <0.0001
Hemoglobin A1C 8.1 (±2.2) 6.9 (±1.0) 0.005
Table 3 Groups after propensity matching; preoperative
data
Radial n=409 Vein n=409 P value
All-cause mortality 18.8% 25.4% 0.0230
Mean age, years 62.4 (±7.4) 63.4 (±7.9) 0.1111
Males 67.24% 68.95% 0.5995
Hispanic 31.05% 28.85% 0.4921
Race
White 62.10% 56.97% 0.2470
African American 12.71% 16.14% 0.4030
Other 25.18% 26.89% 0.8620
Mean EF 47.1 (±12.5) 48.5 (±13.7) 0.1710
Years since surgery 6.5 (±4.2) 6.4 (±3.7) 0.3955
BMI 29.8 (±5.6) 28.6 (±5.7) 0.8130
Transmural MI 33.50% 31.78% 0.6017
Stroke 8.31% 8.56% 0.8999
Carotid disease 8.56% 7.82% 0.7021
Aortoilac disease 2.93% 4.16% 0.3445
Femoral PVD 10.02% 11.00% 0.6484
Hemodynamics unstable 0.73% 1.22% 0.4773
Hypertension 73.84% 73.35% 0.8740
Current CHF 8.07% 7.09% 0.5972
COPD 24.45% 24.225% 1.0000
Ascending aortic disease 4.16% 3.42% 0.5828
Creatinine > 2.5 mg/dL 1.96% 1.96% 1.0000
Coronary vessel disease
Triple 79.4% 82.5% 0.7790
Double 16.5% 13.12% 0.5960
Single 3.1% 3.4% 0.9710
Left main 30.5% 29.7% 0.9065
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patients; RA patients received on average 2.3 arterial grafts
but SV patients received exactly 1.0 arterial graft per
patient. Saphenous vein grafts were generally preferred
over RA to bypass the right coronary system (almost
always to the Posterior Descending artery).
Outcomes and complications for all diabetic patients
are reported in Table 2. Briefly, outcomes were better in
the RA group (RA operative mortality 0.1% vs 1.9% in
the SV group, p<0.0001), and major complications
were significantly less common in the RA group vs SV
(Stroke 0.9% vs 1.25%, p=0.0059; Renal failure 0.9% vs
2.9%, p<0.0001; Respiratory failure 2.65% vs 5.25%,
p<0.0001). Of note, only 2 significant infections occurred
in the forearm and no major peripheral neurologic
injury occurred.
Even before matching the mean duration from surgery
to study was similar for the two groups at just over six
and half years. After propensity matching, long-term
follow-up was similar for RA matched patients at 6.7 ±3.9
years (median 6.49 years) and for SV matched patients
6.9± 4.5 years (median 6.88 years).
Hemoglobin A1c levels as an index of diabetes control
was significantly different and actually worse for the RA
group (8.1± 2.2 vs 6.9 ± 1.0; p =0.005).
Outcomes in the propensity matched patients
Table 3 summarizes the preoperative risk factors for the
RA and SV patients after propensity matching. Our hos-
pital serves many New York immigrant communities
and racial diversity is wide. “Other” in our hospital are
mostly Asian. Reduced RA use in African Americansreflects the high incidence of hypertensive renal dysfunction
in this group. Our bias is to avoid RA harvest in patients
with renal dysfunction to preserve possible dialysis access.
Propensity-matched patients show strikingly similar
demographics and risk factors summarized in Table 3.
Important operative details of propensity matched
groups are reported in Table 4: while aortic cross clamp
time and perfusion time each averaged 10 minutes longer
for the unmatched RA group (p<0.0001), after propensity
matching, the differences between RA and SV groups
remain significant only for cross clamp time. Perhaps
reflecting our philosophy on complete revascularization,
RA patients received slightly more grafts per patient, but
after propensity matching, grafts per patient averaged 3.7
for both groups. For the propensity matched patients,
there were no deaths in either group (hospital mortality
0% RA vs. 0% SV ; p=1).
After propensity matching, postoperative major
complications occurred with equal frequency in each of
Table 4 After propensity matching: operative data/
complications
Radial n=409 Vein n=409 P value
Mean cross-clamp 70.5 (±19.8) 66.7 (±17.6) 0.0110
Mean perfusion 93.9 (±24.7) 91.38 (±27.3) 0.2190
Grafts/patient 3.7 (±0.9) 3.7 (±0.8) 0.3510
Priority
Elective 23.2% 24.6% 0.6636
Urgent 72.8% 69.5% 0.1670
Emergent 3.8% 5.6% 0.2230
Permanent stroke 1.2% 1.2% 1.0000
Perioperative MI 0.50% 0.99% 0.4930
Sternal wound infection 1.5% 3.2% 0.0785
Septicemia 1.5% 1.7% 0.8200
Reoperation for bleeding 1.5% 2.2% 0.4570
Respiratory failure 3.0% 3.2% 0.8690
Renal failure 1.3% 1.5% 0.8080
Hemoglobin A1C 7.62% 7.99% 0.6080
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sternal wound infection was higher in SV this was not
statistically significant). There were a total of 77 late
deaths (18%) in the RA group and 104 deaths (25.4%) in
the SV group; p=0.023. The average time to death was
6.2 ±3.5 years (median 5.8 years) for the RA patients
and 5.8± 3.5 years (median 6.0 years) for the SV patients.
We were not able to differentiate cardiac from other
causes of death. Kaplan Meier actuarial survival curves
derived for RA and SV groups are depicted in Figure 1.
Survival at 1, 5, 10 and 12 years was 98%, 89%, 77 and
70% for RA vs. 96%, 87%, 64% and 59% for SV and thisFigure 1 Kaplan-Meier survival curve of propensity matched 818 diabwas highly statistically significant by Log Rank Test
(p = 0.006).
Cox multivariable analysis determined independent
risk factors predictive of mortality, and these are listed
in Table 5. As expected, age exerts a significant differ-
ence per year and ejection fraction is inversely linked to
mortality. Stroke, peripheral vascular disease and renal
dysfunction exert a strong influence, almost doubling
mortality. There is only a single factor statistically pro-
tective against mortality for diabetic patients: use of the
RA with hazard ratio 0.683 (confidence intervals 0.507 -
0.920, p < 0.0122), suggesting a greater than 30% risk
reduction in mortality attributed to use of the RA in
diabetic patients undergoing CABG.
Discussion
While diabetes is increasing at an alarming rate, coron-
ary artery disease (CAD) is more prevalent among
diabetics and more severe, generally more diffuse, exten-
sive and often more distally distributed [8]. Since the
BARI trial and to the present, as reflected in current
ACC/AHA guidelines [9], compelling evidence supports
referral for surgical revascularization for diabetic
patients with multi vessel CAD. Importantly, however,
even as survival has improved for all groups, survival of
diabetic patients remained worse than non diabetic
patients immediately after surgical revascularization and
at every stage thereafter [10]. Several specific factors
affect diabetics: increased platelet aggregation, increased
platelet adhesion, and increased thrombogenesis likely
contribute to premature graft failure and the increase in
postoperative myocardial ischemic events [11]. Outcomes
are linked to pre-operative control of blood sugar reflected
by Hemoglobin A1C [12]. Naturally, the increasedetic patients after CABG.
Table 5 Independent predictors of mortality (Cox Method)
818 matched diabetic patients
Hazard ratio 95% C I P value
Stroke 1.920 (1.257-2.935) 0.0026
Femoral PVD 2.363 (1.688-3.307) <0.0001
Creatinine > 2.5 2.196 (1.114-4.328) 0.0231
Age (per year) 1.056 (1.036-1.075) <0.0001
EF (per % point) 0.980 (0.969-0.992) 0.0007
Radial Artery Use 0.683 (0.507-0.920) 0.0122
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impact complications associated with harvesting of the
conduit [13].
RA is a versatile arterial bypass conduit: easily harvested,
of appropriate size and easy to handle. In our experience,
RA harvest complications were vanishingly rare: forearm
infections were extremely rare and major nerve injury did
not occur; no patient has any reported or measurable
functional deficit. Choudhary [14] identified augmented
radial vasoreactivity in diabetics compared with non-
diabetics, but the clinical significance is unclear. Distensi-
bility and compliance of RA are not reduced in diabetics
but radial intima-medial thickness and wall cross sectional
area are significantly higher [15]. Visibly calcified or
atherosclerotic RA conduit was discarded but these
circumstances were very rare.
Long term SV patency is rather disappointing in most
reported series. Superior patency of the LITA and the
impact on long term survival is universally acknowledged.
Right ITA patency has also been shown to be superior to
SV [3], but the survival advantage of bilateral ITA grafting
has not been confirmed in all studies. In studies focusing
specifically on diabetic patients, while Lev-Ran [16]
reported survival and MACE benefits for bilateral ITA
grafting in patients on oral diabetic medicines, Hirotani
found no advantage for bilateral ITA in diabetics at 10
years. Excellent graft patency was documented early after
CABG. In many of their patients the RITA was used to
bypass the LAD and the LITA to a lateral wall vessel, a
strategy which makes subsequent reoperative sternotomy
hazardous [17]. Toumpoulis [18] also reported no survival
advantage for diabetic patients at 5 years for bilateral
versus single ITA grafting: it may be that their follow up
period was too short to detect the long term patency
advantages of multiple arterial grafts. By contrast,
however, RAPS [19] reported RA benefit for diabetics
based on a patency rate greater than SV on angiography at
one year. Major concerns persist, especially in diabetics,
about the impact of bilateral ITA harvest on sternal
healing and infection [20]. So it is perhaps not surprising
that, despite the strong evidence in favor of bilateral ITA
use (only some of which is cited above) the STS databaserecords a disappointingly low (4%) use of bilateral ITA
for CABG [21].
We, and others in the USA, Canada, Europe and Australia
[2,3,5,18] have documented excellent mid-term patency of
RA grafts. Guidelines [9] list radial use for CABG as a Class
IIb recommendation: “ Use of a radial artery graft may
be reasonable when grafting left-sided coronary arteries
with severe stenoses (>70%) and right-sided arteries with
critical stenoses (90%) that perfuse LV myocardium.
(Level of Evidence: B )” Despite encouraging outcomes,
RA is used in only 9% of CABG patients in the STS
database [21]. Acar [22] recently published a remarkable
appraisal of a personal 20 year experience in 819 RA
patients of whom a third (32%) were diabetic. The right
coronary artery was the target for the RA graft in 30%
of cases, and would likely not have met the current
guidelines! Conventional angiography or CT was used
to assess almost half the patients (351) a mean of 7 years
after CABG in symptomatic and asymptomatic patients
with no difference in patency between SV and RA (82%
vs 81.9%). Beyond the first year after CABG the RA pa-
tency rate was steady out past 13 years. Notably,
patients in his series received on average just 2.45 grafts
each (his series was not limited to patients operated on
for first time coronary bypass surgery alone), and only
veins of “faultless” quality were used, which likely explains
the extraordinarily high SV patency in his series.
The Toledo group [23] identified a survival benefit for
RA use in young diabetics with triple vessel disease from
their patient cohort of whom 34% were diabetics. How-
ever, in a subsequent report [24], they were unable to
demonstrate a survival benefit for RA grafting in 950
propensity matched diabetic patients, separated into in-
sulin and no-insulin categories. They did not have data
on graft patency rates, or cause of death, and included
operative deaths in their analysis. Late mortality for their
RA patients was higher than in our experience, and their
reported mortality was similar to that in our SV patients.
With a shorter follow up interval than ours, they had
only 28 RA patients at risk at 10 years. In many ways
our experience parallels theirs, and it is quite striking
that the relative risk reduction afforded by RA use in
their unmatched patients (n=566, 151 of 626 RA
compared with 415 of 890 SV) analyzed after risk ad-
justment is remarkably similar (30%) to the 32% we
found for our 818 propensity matched patients. How-
ever while their comparison of unmatched but risk
adjusted groups failed to reach statistical significance
(95% CI 0.36 -1.37; p= 0.29) our propensity matched
comparison of larger RA and SV groups showed the
32% relative risk reduction achieved in our RA group to
be highly statistically significant and therefore RA use in
our series statistically predicts better survival (HR 0.683,
CI 0.507- 0.920, p=0.0122).
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harvested saphenous veins [25], our experience provides
comforting evidence that endoscopic harvest does not
compromise graft patency or patient survival. Despite
improved systems for endoscopic harvest, it must be
emphasized that the level of technical proficiency
required to harvest the RA arterial conduit is substantial
and remains highly operator dependant.
Limitations
Although our analysis is retrospective, preoperative, op-
erative and in-hospital postoperative data are derived from
a mandatory, audited state database and were collected
and recorded prospectively. Only isolated primary CABG
patients were analyzed, and this series represents the
largest single site consecutive experience with standardized
techniques. Survival data are derived from the Social Secur-
ity Death Index with its known imperfections. Although a
propensity match is considered the appropriate statistical
tool to compare outcomes of different treatments, this
may not adjust fully for selection bias (surgeon choice)
and patient heterogeneity.
Conclusion
In diabetic patients who have coronary revascularization
with LITA to the LAD, the addition of a radial artery
graft produces a significant and sustained improvement
in long-term survival, when compared with LITA and
SV grafting. This reinforces our hypothesis that use of
the radial conduit can overcome the previously universally
acknowledged worse long-term outlook for diabetic patients
after coronary bypass surgery. With these data, optimal
revascularization for diabetic patients is better defined.
Implications
Our findings have important implications for planning
the initial revascularization strategy for every diabetic
patient with multivessel coronary disease.
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